Charles River Laboratories terminates agreement to acquire WuXi PharmaTech - MarketLine Financial Deals

Charles River Laboratories terminates agreement to acquire WuXi PharmaTech

Charles River Laboratories terminates agreement to acquire WuXi PharmaTech - MarketLine Financial Deals
Charles River Laboratories terminates agreement to acquire WuXi PharmaTech
Published Jul 29, 2010
5 pages — Published Jul 29, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Charles River Laboratories International, Inc. (CRL), a US-based provider of tailored research models and laboratory animal support services, has terminated its agreement o acquired WuXi PharmaTech (Cayman), Inc., a China-based pharmaceutical, biotechnology and medical device research and development outsourcing company.

  
Source:
Document ID
MA23847_100427
Country
Country
Ticker
CRL=US
Ticker
WX=CN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Charles River Laboratories terminates agreement to acquire WuXi PharmaTech" Jul 29, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Charles-River-Laboratories-terminates-agreement-to-acquire-WuXi-PharmaTech-2052-31799>
  
APA:
MarketLine Financial Deals. (2010). Charles River Laboratories terminates agreement to acquire WuXi PharmaTech Jul 29, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Charles-River-Laboratories-terminates-agreement-to-acquire-WuXi-PharmaTech-2052-31799>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.